The 20 cents cap is healthy to consolidate our quick advance, good opportunity to add below 20 cents, which, as I see it, might not last long.
When 20 cents breaks, new resistance/ support levels will come into play and we could
look at some considerable upward movements.
Fundamentals are your friend in this one as latest board additions in the US, tox reports and
extended trials with larger target patient groups are in place.
Once market gets a proper idea about the ramifications of our CNS candidate, this will rerate, IMO.
Company Actively Progressing Discovery Activities in Neurodegenerative Diseases and Remains on Track to Nominate a CNS Development Candidate In 2021
Exciting times for technology breakthroughs by several companies in the field, as mentioned by other posters, indicating our own strong strategic position.
all IMO
PYC Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)